Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 2 February 2009, doi:10.1136/bmj.b398
Cite this as: BMJ 2009;338:b398
| The first 150 words of the full text of this article appear below. |
I thought that it might be helpful to set the record straight on the undergraduate curriculum at Brighton and Sussex Medical School (BSMS).1
The student selected project on drug development is precisely that: student selected. It is not core material, and in fact comparatively few students have chosen to take it. It is not concerned with the teaching of clinical pharmacology or therapeutics but with understanding the complexities of pharmaceutical research and development.
Core teaching of clinical pharmacology and therapeutics is undertaken throughout the BSMS undergraduate programme, and rapid responders to the news story who believe that this student selected component contributes to this have misunderstood.2 The BSMS course has very recently been assessed and approved by the General Medical Council, and indeed as part of the recent quality assurance process an external examiner (a clinical pharmacologist) commented that he "was particularly pleased to see a distinct emphasis on therapeutics
Martin Llewelyn, senior lecturer, infectious diseases and therapeutics1
1 Brighton and Sussex Medical School (BSMS), University of Sussex, Brighton, East Sussex BN1 9PX
m.j.llewelyn@bsms.ac.uk